MRC Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, Imperial College London, London, UK.
Malaria Epidemiology Unit, Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK; Kenya Medical Research Institute, University of Oxford-Wellcome Trust Collaborative Programme, Kenyatta National Hospital Grounds, Nairobi, Kenya.
Lancet Glob Health. 2014 Aug;2(8):e460-7. doi: 10.1016/S2214-109X(14)70256-6. Epub 2014 Jul 23.
Plasmodium falciparum infection during pregnancy leads to adverse outcomes including low birthweight; however, contemporary estimates of the potential burden of malaria in pregnancy in Africa (in the absence of interventions) are poor. We aimed to estimate the need to protect pregnant women from malaria across Africa.
Using a mathematical model applied to estimates of the geographical distribution of P falciparum across Africa in 2010, we estimated the number of pregnant women who would have been exposed to infection that year in the absence of pregnancy-specific intervention. We then used estimates of the parity-dependent acquisition of immunity to placental infection and associated risk of low birthweight to estimate the number of women who would have been affected.
We estimate that, without pregnancy-specific protection, 12·4 million pregnant women (44·9% of all 27·6 million livebirths in malaria endemic areas in Africa in 2010) would have been exposed to infection, with 11·4 million having placental infection (41·2% of all livebirths). This infection leads to an estimated 900,000 (95% credible interval [CrI] 530,000-1,240,000) low birthweight deliveries per year. Around the end of the first trimester, when the placenta becomes susceptible to infection, is a key period during which we estimate that 65·2% (95% CrI 60·9-70·0) of placental infections first occur.
Our calculations are the only contemporary estimates of the geographical distribution of placental infection and associated low birthweight. The risk of placental infection across Africa in unprotected women is high. Prevention of malaria before conception or very early in pregnancy is predicted to greatly reduce incidence of low birthweight, especially in primigravidae. The underlying lifetime risk of low birthweight changes slowly with decreasing transmission, drawing attention to the need to maintain protection as transmission falls.
Malaria in Pregnancy Consortium and the Bill & Melinda Gates Foundation.
孕妇感染恶性疟原虫可导致包括低出生体重在内的不良后果;然而,目前对非洲(无干预措施情况下)妊娠期间疟疾潜在负担的估计较差。我们旨在估算在整个非洲为孕妇提供疟疾保护的需求。
我们使用一种数学模型,根据 2010 年非洲恶性疟原虫的地理分布估计数,估算当年在无妊娠特异性干预的情况下,有多少孕妇会受到感染。然后,我们利用对胎盘感染相关低出生体重获得性免疫的孕次依赖性估计数和相关风险,估算受影响的妇女人数。
我们估计,如果没有妊娠特异性保护,1240 万孕妇(2010 年非洲疟疾流行地区 2760 万活产儿的 44.9%)会受到感染,其中 1140 万孕妇会发生胎盘感染(所有活产儿的 41.2%)。这种感染估计每年导致 90 万(95%可信区间 [CrI] 53 万-124 万)例低出生体重分娩。在妊娠早期结束时,胎盘易受感染,这是一个关键时期,我们估计有 65.2%(95%CrI 60.9-70.0)的胎盘感染首次发生在此期间。
我们的计算是目前唯一对胎盘感染和相关低出生体重的地理分布的估计。未受保护的妇女在整个非洲感染胎盘的风险很高。在妊娠前或妊娠早期不久预防疟疾,预计会大大降低低出生体重的发生率,尤其是在初产妇中。随着传播的减少,低出生体重的终生风险变化缓慢,这引起人们对随着传播的减少而保持保护的必要性的关注。
妊娠疟疾联盟和比尔及梅琳达·盖茨基金会。